HRS-9057
/ Jiangsu Hengrui Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
November 18, 2025
A Study of HRS-9057 in Patients With Heart Failure and Volume Overload
(clinicaltrials.gov)
- P1 | N=25 | Completed | Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. | Not yet recruiting ➔ Completed | Trial completion date: Oct 2024 ➔ Oct 2025 | Trial primary completion date: Sep 2024 ➔ Oct 2025
Trial completion • Trial completion date • Trial primary completion date • Cardiovascular • Congestive Heart Failure • Heart Failure
July 18, 2024
A Study of HRS-9057 in Patients With Heart Failure and Volume Overload
(clinicaltrials.gov)
- P1 | N=24 | Not yet recruiting | Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd.
New P1 trial • Cardiovascular • Congestive Heart Failure • Heart Failure
1 to 2
Of
2
Go to page
1